Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
NITTO KOGYO, Oct-Dec (3Q) Ordinary Profit Increases by 17%
6651 NITTO KOGYO CORPORATION 【J-GAAP】
Earnings ReportNITTO KOGYO CORPORATION <6651> [TSE Prime] announced its financial results after the market closed on February 10th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) was 9.5 billion yen, a 0.03% decrease compared to the same period last year. The progress rate toward the full-year plan of 12 billion yen was 79.2%, also surpassing the five-year average of 74.8%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to decrease 18.4% from the same period last year to 2.49 billion yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit grew 17.4% from the same period last year, reaching 5.07 billion yen. The operating profit margin improved from 9.7% in the same period last year to 10.2%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 104,985 | 5,326 | 6,096 | 3,769 | 99.4 | 67.3 | Feb 6, 2023 | J-GAAP |
Apr - Dec, 2023 | 116,907 | 8,996 | 9,506 | 6,612 | 174.3 | 75.6 | Feb 5, 2024 | J-GAAP |
Apr - Dec, 2024 | 133,354 | 9,298 | 9,503 | 9,014 | 237.6 | 79.2 | Feb 10, 2025 | J-GAAP |
YoY | +14.1% | +3.4% | 0.0% | +36.3% | +36.3% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 87,546 | 7,196 | 7,379 | 5,151 | 135.8 | 158 | May 15, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 96,017 | 7,937 | 7,567 | 4,788 | 126.2 | 68 | Nov 5, 2024 | J-GAAP |
YoY | +9.7% | +10.3% | +2.5% | -7.0% | -7.1% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 146,698 | 8,172 | 9,056 | 5,479 | 144.5 | 145 | May 15, 2023 | J-GAAP |
Mar, 2024 | 160,709 | 11,967 | 12,566 | 8,715 | 229.8 | 230 | May 15, 2024 | J-GAAP |
Mar, 2025 Guidance | 178,000 | 12,000 | 12,000 | 10,000 | 263.6 | 132 | Nov 5, 2024 | J-GAAP |
YoY | +10.8% | +0.3% | -4.5% | +14.7% | +14.7% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 43,744 | 4,225 | 4,319 | 3,048 | 80.4 | 9.7 | Feb 5, 2024 | J-GAAP |
Jan - Mar, 2024 | 43,802 | 2,971 | 3,060 | 2,103 | 55.5 | 6.8 | May 15, 2024 | J-GAAP |
Apr - Jun, 2024 | 38,742 | 1,601 | 1,996 | 3,704 | 97.7 | 4.1 | Aug 5, 2024 | J-GAAP |
Jul - Sep, 2024 | 43,241 | 2,462 | 2,437 | 1,508 | 39.8 | 5.7 | Nov 5, 2024 | J-GAAP |
Oct - Dec, 2024 | 51,371 | 5,235 | 5,070 | 3,802 | 100.2 | 10.2 | Feb 10, 2025 | J-GAAP |
YoY | +17.4% | +23.9% | +17.4% | +24.7% | +24.7% |
Related Articles
KI-STAR REAL ESTATE, The Current Fiscal Year Ordinary Profit Revised Upward by 17%, Dividend Revised Upward by 18 yen
Monogatari, First Half Ordinary Profit Increases by 0.4%
SINANEN HOLDINGS, Apr-Dec (Cumulative 3Q) Ordinary Profit Turns to Profit, Oct-Dec Ordinary Profit Increases by 9.6 times
MARUYAMA MFG, Oct-Dec (1Q) Ordinary Profit Loss Widens
SoftBank Corp, Apr-Dec (Cumulative 3Q) Net Income Increases by 7%
DAITO KOUN, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 7%, Oct-Dec Ordinary Profit Increases by 25%
CELM Inc, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 7%, Oct-Dec Ordinary Profit Decreases by 10%
TAZMO, Last Fiscal Year Ordinary Profit Revised Upward by 33%, Raises Record High Profit Forecast
KOBAYASHI PHARMA, 43% Decrease in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen
Immuno-Biological Lab, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 5.2 times, Exceeds Full-Year Plan